Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04908423 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Xeomin® and Gait Related Mobility After Stroke

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Apr 2026 to Apr 2027
    • Site contact updated
    v11
  2. Re-verified, no change to tracked fieldsv10
  3. Primary and study completion dates: Apr 2024 to Apr 2026
    • Site contact updated
    v9
  4. Primary and study completion dates: May 2023 to Apr 2024v8
  5. Site contact updatedv7
Show 5 earlier versionsHide 5 earlier versions
  1. Re-verified, no change to tracked fieldsv6
  2. Site contact updatedv5
  3. Start date changed from estimate of Oct 2021 to Oct 19, 2021v4
  4. Start date: Aug 2021 to Oct 2021v3
  5. Start date: Jun 2021 to Aug 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the present pilot study is to evaluate the association between change in gait related mobility in ambulatory male and female adult hemiparetic patients before and 4-6-weeks after Xeomin® injection into the upper limb, using two standardized tests of physical function in outpatient rehabilitation that are widely used; the 10-meter walk test and the timed 'up and go' test (TUG).
Trial Details
NCT Number NCT04908423
Lead Sponsor Wake Forest University Health Sciences
Collaborators: Merz Pharmaceuticals GmbH
Conditions
(from sponsor)		 Stroke
Related terms Stroke
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov